Relationship Between Mepacrine-Labelled Dense Body Number, Platelet Capacity to Accumulate 14C-5-HT and Platelet Density in the Bernard-Soulier and Hermansky-Pudlak Syndromes

F Rendu; A T Nurden; M Lebret; J P Caen

doi:10.1055/s-0038-1666908

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1979; 42(02): 694-704
DOI: 10.1055/s-0038-1666908

Original Article

Schattauer GmbH Stuttgart

Relationship Between Mepacrine-Labelled Dense Body Number, Platelet Capacity to Accumulate ¹⁴C-5-HT and Platelet Density in the Bernard-Soulier and Hermansky-Pudlak Syndromes

F Rendu

The Unité 150 INSERM et ERA 335 CNRS, Hôpital Lariboisière, 75475 Paris Cedex 10 (France)

,

A T Nurden

The Unité 150 INSERM et ERA 335 CNRS, Hôpital Lariboisière, 75475 Paris Cedex 10 (France)

,

M Lebret

The Unité 150 INSERM et ERA 335 CNRS, Hôpital Lariboisière, 75475 Paris Cedex 10 (France)

,

J P Caen

The Unité 150 INSERM et ERA 335 CNRS, Hôpital Lariboisière, 75475 Paris Cedex 10 (France)

› Institutsangaben

Abstract

als PDF herunterladen

Summary

We have used the mepacrine-labelling procedure to measure the dense body (serotonin storage organelle) content of the platelets of 2 hereditary disorders where abnormalities in dense body number were suspected. The platelets were incubated with mepacrine and examined by fluorescence microscopy. A mean number of 5.4 ± 0.8 (SD) dense bodies per platelet was calculated from the data obtained using platelets isolated from 40 normal human subjects. In contrast the platelets of 2 patients with the Bernard-Soulier syndrome contained an average of 14 and 17 labelled granules. This increase was associated with a much greater capacity of the platelets to accumulate ¹⁴C-5-HT. The opposite result was obtained using the platelets from 2 patients with the Hermansky-Pudlak syndrome which contained few granules labelled by mepacrine and took up less ¹⁴C-5-HT than normal human platelets. Centrifugation of the patients’ platelets on discontinuous sucrose gradients showed that the platelets of the 2 Bemard-Soulier patients were much denser than normal whereas a high proportion of low density platelets was observed in the Hermansky-Pudlak syndrome. These results further define the platelet abnormalities in the two syndromes and suggest that dense body number may be one of the factors governing platelet density.

PDF (359 kb)

Referenzen

References
1 Bernard J, Soulier JP. 1948; Sur une nouvelle variété de dystrophie thrombocytaire hémorragipare cong�nitale. Sem. Hôp. Paris 24: 3217
2 Bithell TC, Parekh SJ, Strong RR. 1972; Platelet function studies in the Bemard-Soulier syndrome. Annals of the New York Academy of Science 201: 145
3 Booyse F, Rafelson MF. 1969. Protein synthesis and platelet function. In JOHNSON SA, Guest MM. “Dynamics of thrombus formation and dissolution”. Ed Lippincott; Philadelphia: 1969. p 149
4 Caen J, Cousin C, Vainer H, Michel H. 1967; Enzymatic activities ADP-induced aggregation and survival in vivo as criteria of platelet viability during storage. Transfusion 7: 143
5 Caen JP, Nurden AT, Jeanneau C, Michel H, Tobelem G, Levy-Toledano S, Sultan Y, Valensi F, Bernard J. 1976; Bemard-Soulier syndrome: a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein. Journal of Laboratory and Clinical Medicine 87: 586
6 Costa JL, Reese TS, Murphy DL. 1974; Serotonin storage in platelets: estimation of storage-packet size. Science 193: 537
7 Da Prada M, Pletscher A. 1975; Accumulation of basic drugs in 5-hydroxytryptamine organelles of blood platelets. European Journal of Pharmacology 32: 179
8 Evensen SA, Solum NO, Grottum KA, Hovig T. 1974; Familial bleeding disorder with a moderate thrombocytopenia and giant blood platelets. Scandinavian Journal of Haematology 13: 203
9 Frojmovic MM, Milton JG, Caen JP, Tobelem G. 1978; Platelets from giant platelet syndrome (BSS) are discocytes and normal sized. Journal of Laboratory and Clinical Medicine 91: 109
10 Grottum KA, Solum NO. 1969; Congenital thrombocytopenia with giant platelets: a defect in the platelet membrane. British Journal of Haematology 16: 277
11 Hardisty RM, Hutton RA. 1967; Bleeding tendency associated with a “new” abnormality of platelet behaviour. Lancet 1: 983
12 Hardisty RM, Mills DC B, KETSA-ARD K. 1972; The platelet defect associated with albinism. British Journal of Haematology 23: 679
13 Hermansky F, Pudlak P. 1959; Albinism associated with hemorrhagic diathesis and unusual pigmented reticular cells in the bone marrow: report of two cases with histochemical studies. Blood 14: 162
14 Karpatkin S. 1978; Heterogeneity of human platelets. VI. Correlation of platelet function with platelet volume. Blood 51: 307
15 Lorez HP, Da Prada A, Pletscher A. 1975; Flashing phenomenon in blood platelets stained with fluorescent basic drugs. Experientia 31: 593
16 Lorez HP, Da Prada M, Rendu F, Pletscher A. 1977; Mepacrine a tool for investigating the 5-hydroxytryptamine organelles of blood platelets by fluorescence microscopy. Journal of Laboratory and Clinical Medicine 89: 200
17 Maldonado JE, Gilchrist GS, Brigden LP, Bowie EJ W. 1975; Ultrastructure of platelets in Bemard-Soulier syndrome. Mayo Clinic Proceedings 50: 402
18 Malmsten C, Kindahl H, Samuelsson B, Levy-Toledano S, Tobelem G, Caen JP. 1977; Thromboxane synthesis and the platelet release reaction in Bernard-Soulier syndrome, thrombasthenia Glanzmann and Hermansky-Pudlak syndrome. British Journal of Haematology 35: 511
19 Nurden AT, Caen JP. 1978; Annotation: Membrane glycoproteins and human platelet function. British Journal of Haematology 38: 155
20 Pareti FI, Day J, Mills DC B. 1974; Nucleotide and serotonin metabolism in platelets with defective secondary aggregation. Blood 44: 789
21 Picottt GB, Da Prada M, Pletscher A. 1976; Uptake and liberation of mepacrine in blood platelets. Naunyn-Schmiedeberg’s Archives of Pharmacology 292: 127
22 Rendu F, Caen JP. 1973; Effect of reserpine on¹⁴C-serotonin uptake by human platelet populations. Haemostasis 1: 161
23 Rendu F, Breton-Gorius J, Trugnan G, Castro-Malaspina H, Rieu JM, Bereziat G, Lebret M, Caen JP. 1979; Studies on a new variant of the Hermansky-Pudlak syndrome: qualitative, ultrastructural and functional abnormalities of the platelet dense bodies associated with a phospholipase A defect. American Journal of Hematology 4: 387
24 Schick PK, Yu BP. 1973; Methylene blue-induced serotonin release in human platelets. Journal of Laboratory and Clinical Medicine 82: 546
25 Walsh PN, Mills DC B, Pareti FI, Stewart GJ, Macfarlane DE, Johnson MM, Egan JJ. 1975; Hereditary giant platelet syndrome. Absence of collagen-induced coagulant activity and deficiency of Factor XI binding to platelets British Journal of Haematology 29: 639
26 Weiss HJ, Tschopp TB, Baumgartner HR, Sussman IA, Johnson MJ, Egan JJ. 1974; a Decreased adhesion of giant (Bernard-Soulier) platelets to subendothelium. Further implications on the role of the von Willebrand factor in haemostasis American Journal of Medicine 57: 920
27 Weiss HJ, Tschopp TB, Rogers J, Brand H. 1974; b Studies of platelet 5-hydroxytryptamine (serotonin) in storage pool disease and albinism. Journal of Clinical Investigation 54: 421
28 White JG, Edson JR, Desnick SJ, Witkop CJ. 1971; Studies of platelets in a variant of the Hermansky-Pudlak syndrome. American Journal of Pathology 63: 319
29 Witkop CJ, Hill CW, Desnick S, Thies JK, Thorn ML, Jenkins M, White JG. 1973; Ophthalmologic, biochemical, platelet and ultrastructural defects in the various types of oculocutaneous albinism. Journal of Investigative Dermatology 60: 443
30 Zeigler Z, Murphy S, Gardner FH. 1978; Microscopic platelet size and morphology in various hematologic disorders. Blood 51: 479